Ardelyx (ARDX) Cash & Equivalents (2013 - 2026)
Ardelyx (ARDX) posted Cash & Equivalents of $31.2 million for Q1 2026, down 54.1% on a QoQ basis from $68.0 million in Q4 2025, and up 1.3% year-over-year from $30.8 million in Q1 2025.
Ardelyx (ARDX) Cash & Equivalents (2013 - 2026) Analysis & Trends
Ardelyx's Cash & Equivalents history runs 14 years deep, the most recent figure standing at $31.2 million for Q1 2026.
- Quarterly Cash & Equivalents rose 1.3% year-over-year to $31.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.2 million (up 1.3% YoY) and the FY2025 annual result came in at $68.0 million, up 4.72% from the prior year.
- Cash & Equivalents was $31.2 million for Q1 2026 at Ardelyx, down from $68.0 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $96.1 million in Q4 2022 and bottomed at $21.5 million in Q4 2023.
- A 5-year average of $52.3 million and a median of $47.1 million in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents sank 77.67% — and 2024, when it surged 202.43%.
- Ardelyx's Cash & Equivalents stood at $96.1 million in 2022, then sank by 77.67% to $21.5 million in 2023, then jumped by 202.43% to $64.9 million in 2024, then rose by 4.72% to $68.0 million in 2025, then plunged by 54.1% to $31.2 million in 2026.
- Business Quant data shows ARDX's Cash & Equivalents at $31.2 million in Q1 2026, $68.0 million in Q4 2025, and $42.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 31.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.21 Mn |
| Dec 31, 2025 | 68.00 Mn |
| Sep 30, 2025 | 42.72 Mn |
| Jun 30, 2025 | 90.05 Mn |
| Mar 31, 2025 | 30.81 Mn |
| Dec 31, 2024 | 64.93 Mn |
| Sep 30, 2024 | 47.43 Mn |
| Jun 30, 2024 | 41.89 Mn |
| Mar 31, 2024 | 36.15 Mn |
| Dec 31, 2023 | 21.47 Mn |
| Sep 30, 2023 | 33.77 Mn |
| Jun 30, 2023 | 30.06 Mn |
| Mar 31, 2023 | 92.49 Mn |
| Dec 31, 2022 | 96.14 Mn |
| Sep 30, 2022 | 61.63 Mn |
| Jun 30, 2022 | 53.41 Mn |
| Mar 31, 2022 | 47.08 Mn |
| Dec 31, 2021 | 72.43 Mn |
| Sep 30, 2021 | 75.29 Mn |
| Jun 30, 2021 | 86.75 Mn |